3D‐Bioprinting for Precision Microtissue Engineering: Advances, Applications, and Prospects
Advanced Healthcare Materials · 2025-04 · 14 (10)
DOI: 10.1002/adhm.202403781 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.12.2024. Verfasst von Jinrun Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hepato-Pancreato-Biliary Center, Beijing Tsinghua Changgung Hospital, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education/Beijin…. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Bioprinting, Tissue Engineering. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 129 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Microtissues, engineered to emulate the complexity of human organs, are revolutionizing the fields of regenerative medicine, disease modelling, and drug screening. Despite the promise of traditional microtissue engineering, it has yet to achieve the precision required to fully replicate organ‐like structures. Enter 3D bioprinting, a transformative approach that offers unparalleled control over the microtissue's spatial arrangement and mechanical properties. This cutting‐edge technology enables the detailed layering of bioinks, crafting microtissues with tissue‐like 3D structures. It allows for the direct construction of organoids and the fine‐tuning of the mechanical forces vital for tissue maturation. Moreover, 3D‐printed devices provide microtissues with the necessary guidance and microenvironments, facilitating sophisticated tissue interactions. The applications of 3D‐printed microtissues are expanding rapidly, with successful demonstrations of their functionality in vitro and in vivo. This technology excels at replicating the intricate processes of tissue development, offering a more ethical and controlled alternative to traditional animal models. By simulating in vivo conditions, 3D‐printed microtissues are emerging as powerful tools for personalized drug screening, offering new avenues for pharmaceutical development and precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hepato-Pancreato-Biliary Center, Beijing Tsinghua Changgung Hospital, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education/Beijing), School of Clinical Medicine, Tsinghua University, Beijing, 102218,…
- Clinical Translational Science Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, 102218, China.
- Beijing Institute of Graphic Communication, Beijing, 102600, China.
ORCID-Profile: Juan Liu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Beijing Tsinghua Changgung Hospital Foundation
Zitieren
APA
Liu, J., Wang, Q., Le, Y., Hu, M., Li, C., An, N., Song, Q., Yin, W., Ma, W., Pan, M., Feng, Y., Wang, Y., Han, L., & Liu, J. (2025). 3D‐Bioprinting for Precision Microtissue Engineering: Advances, Applications, and Prospects. Advanced Healthcare Materials, 14(10). https://doi.org/10.1002/adhm.202403781
Vancouver
Liu J, Wang Q, Le Y, Hu M, Li C, An N, et al. 3D‐Bioprinting for Precision Microtissue Engineering: Advances, Applications, and Prospects. Advanced Healthcare Materials. 2025;14(10). doi:10.1002/adhm.202403781
BibTeX
@article{Liu2025,
author = {Liu, Jinrun and Wang, Qi and Le, Yinpeng and Hu, Min and Li, Chen and An, Ni and Song, Qingru and Yin, Wenzhen and Ma, Wenrui and Pan, Mingyue and Feng, Yutian and Wang, Yunfang and Han, Lu and Liu, Juan},
title = {3D‐Bioprinting for Precision Microtissue Engineering: Advances, Applications, and Prospects},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {10},
doi = {10.1002/adhm.202403781}
}
EUVIMED